LGALS1 and peripheral T-cell lymphoma, not otherwise specified: The prognosis of peripheral T-cell lymphoma patients is significantly poor, and high intratumoral galectin-1 expression before treatment was associated with adverse outcomes in a cohort of patients with CD30+ and ALK− peripheral T-cell lymphoma (106).